Article | April 9, 2024

Get Predictive Insight Into Your ADC's Stability With These 3 Experiments

Antibody drug conjugates ADCs GettyImages-1715913285

Review the use of Prometheus Panta in predictive stability experiments for the development of Antibody-drug conjugates (ADCs). To emphasizes the importance of protein assessment to prevent destabilizing the final product, data was compiled comparing three therapeutics: Herceptin, Kadcyla, and RC48, in terms of kinetic stability and half-life. This article outlines the process of conducting thermal stability experiments and the significance of self-association parameters. The results indicate that Herceptin has the highest kinetic stability and half-life, while RC48 is the least stable.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

NanoTemper Technologies, Inc.